PR out for moderate/severe Brazilian trial. “
Post# of 148132
“ CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients”
Critical should follow this week.
Https://www.cytodyn.com/investors/news-events/press-releases/detail/547/cytodyn-receives-clearance-from-brazils-anvisa-to